Two EMBL scientists awarded ERC Consolidator Grants
EMBL group leaders Isidro Cortes-Ciriano and Wojciech Galej received ERC Consolidator Grants for their work on how genome structure and gene regulation shape human disease.
2025
announcements
Researchers uncover what drives aggressive bone cancer
Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes.
SCIENCE & TECHNOLOGY2025
research-highlightsscience-technology
EMBL-EBI co-leads on research programme to help treat relapsed childhood cancers
Leading charities Children with Cancer UK and Cancer Research UK will co-fund a major £5.5 million research programme to advance precision medicine for relapsed childhood cancers.
2023
announcements
Uncovering the mechanisms underlying lack of response to immunotherapy
New research improves understanding of the molecular mechanisms behind why some cancers respond to immunotherapy and others don't.
SCIENCE & TECHNOLOGY2023
research-highlightssciencescience-technology
No results found